+ 2.69
+ 1.88%

Where HCA Healthcare Stands With Analysts

April 26, 2021 2:13 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

HCA Healthcare (NYSE:HCA) has observed the following analyst ratings within the last quarter:

Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago
Bullish 0 5 0 1
Somewhat Bullish 0 2 0 2
Indifferent 2 0 0 0
Somewhat Bearish 0 0 0 0
Bearish 0 0 0 0

In the last 3 months, 12 analysts have offered 12-month price targets for HCA Healthcare. The company has an average price target of $215.17 with a high of $232.00 and a low of $190.00.

price target chart

This current average has increased by 12.07% from the previous average price target of $192.0.

How Are Analyst Ratings Determined?

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Analysts can recommend “buy”, “sell”, “hold”, or similar verbage for each stock based on that company’s recent performance. “Buy” indicates that an analyst is optimistic about a stock’s short-term or mid-term growth and is a recommendation to purchase the stock. On the other hand, “Sell” implies that an analyst forecasts a downwards trend for the stock. “Hold” suggests that investors should maintain their positions on that stock because of forecasted stagnation or lack of new information.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.


Analyst Ratings

Related Articles

Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2021

  read more

BMO Capital Maintains Market Perform on HCA Healthcare, Raises Price Target to $222

BMO Capital analyst Matt Borsch maintains HCA Healthcare (NYSE:HCA) with a Market Perform and raises the price target from $200 to $222. read more

Citigroup Downgrades HCA Healthcare to Neutral, Announces $215 Price Target

Citigroup analyst Ralph Giacobbe downgrades HCA Healthcare (NYSE:HCA) from Buy to Neutral and announces $215 price target. read more

Deutsche Bank Maintains Buy on HCA Healthcare, Raises Price Target to $225

Deutsche Bank analyst Pito Chickering maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $210 to $225. read more